ArticleLung Cancer (Auckland, N.Z.)2024

Spotlight on Patritumab Deruxtecan (HER3-DXd) from HERTHENA Lung01. Is a Median PFS of 5.5 Months Enough in Light of FLAURA-2 and MARIPOSA?

Zhaohui Liao Arter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.